Published • loading... • Updated
Pediatric oncology nurse answers some of the most pressing questions about high-risk neuroblastoma
The Q&A says about one-third of children relapse after aggressive therapy and explains how maintenance treatment may help keep remission.
- On Tuesday, Childhood Cancer Awareness Month highlighted pediatric cancers as Michele Ritter, Clinical Nurse Educator at WorldMeds, addressed common questions about high-risk neuroblastoma.
- "Neuroblastoma is a cancer that develops from immature nerve cells and most commonly affects infants and young children," said Ritter, noting the disease is aggressive with significant relapse risk.
- Achieving remission is a major milestone, yet cancer recurrence remains a concern even when scans show no disease; physicians may recommend maintenance therapy to reduce relapse risk.
- Parents and families often spend years navigating appointments and treatments, proving caregivers are unsung heroes throughout the cancer journey and advocating for children every step of the way.
- Families should know there is reason for hope as advances in research continue to improve outcomes, with advocacy groups providing support and resources for affected children.
Insights by Ground AI
22 Articles
22 Articles
thepampanews.com+21 Reposted by 21 other sources
Pediatric oncology nurse answers some of the most pressing questions about high-risk neuroblastoma
(BPT) - September is Childhood Cancer Awareness Month, a time to raise awareness of pediatric cancers and recognize the children and families affected by these diseases.According to Children's Cancer Cause, approximately 15,000 children and adolescents are diagnosed with cancer each year in the U.S. There are more than 13 major types of pediatric cancers and more than 200 subtypes. One rare but incredibly challenging type of childhood cancer is …
·Pampa, United States
Read Full ArticleCoverage Details
Total News Sources22
Leaning Left2Leaning Right2Center17Last UpdatedBias Distribution81% Center
Bias Distribution
- 81% of the sources are Center
81% Center
C 81%
Factuality
To view factuality data please Upgrade to Premium
